Johnson & Johnson (BUE:DJNJ3) FFO


BUE:DJNJ3 Johnson & Johnson BUE:DJNJ3
81 GF Score
Price ARS1,640.00
GF Value ARS1,189.85
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson FFO?

FFO (Funds from operations) only applies to REITs.

BUE:DJNJ3
81GF Score
Johnson & Johnson BUE:DJNJ3
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Johnson & Johnson (BUE:DJNJ3) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of ARS1,640.00 is trading 37.8% above its estimated GF Value™ of ARS1,189.85.

Key valuation signals for BUE:DJNJ3:

  • FFO:
  • GF Value™: ARS1,189.85 vs. price of ARS1,640.00 (37.8% above fair value)
  • GF Score™: 81/100 with 7 warning signs

No single metric tells the full story. See the BUE:DJNJ3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
81GF Score

Get the complete analysis for BUE:DJNJ3

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS1,640.00
Price
ARS1,189.85
GF Value